Health IT AnalyticsNIH Partnership Seeks to Advance Cancer Immunotherapy ResearchSpecialty Pharmacy Times (blog)“This new public-private partnership is a significant step forward in the battle against cancer and a real boost to the potential of immunot… Continue reading
Innovators MagazineNew system could short circuit cancer | Innovators magazineInnovators MagazineMIT researchers have created a synthetic gene circuit system that uses the immune system to fight cancer at its source.and more »… Continue reading
Kansas City Business JournalGene therapy helped these children see. Can it transform medicine?Kansas City Business JournalOver home-made brownies and iced tea, Caroline and Cole tell me how they received a pioneering treatment known as gene therapy on … Continue reading
San Francisco Business TimesGene therapy helped these children see. Can it transform medicine?San Francisco Business TimesOver home-made brownies and iced tea, Caroline and Cole tell me how they received a pioneering treatment known as gene therapy on … Continue reading
Genetic Engineering & Biotechnology News (press release)Skin Cancer Starts When Tanning Goes Wrong in Mutated Stem CellsGenetic Engineering & Biotechnology News (press release)Skin cancer has been traced back to the ultraviolet stimulation of melanocyt… Continue reading
FDA approves gene therapy to treat adult lymphomaTribune-ReviewOn Wednesday, Oct. 18, 2017, the Food and Drug Administration approved sales of the therapy Yescarta, developed by Kite Pharma. It is the second gene therapy for U.S. patients _ the first o… Continue reading
|
Kite Pharma’s CAR T-Cell Treatment Approved, Cheaper Than Tisagenlecleucel
AJMC.com Managed Markets Network The FDA has given the go-ahead for a second chimeric antigen receptor (CAR) T cell therapy: axicabtagene ciloleucel (Yescarta), developed by Kite Pharma, which was recently acquired by Gilead Sciences, has been approved to treat adult patients with … |
|
‘Stings & Things’: Noted Allergist Discusses Venom Immunotherapy at WRNMMC
Pentagram Golden provided the Walter Reed Bethesda allergists, pediatricians and internal medicine primary care providers with clinical and research information pertaining to measures to avoid getting stung, risks for severity and dosing for venom immunotherapy … |